BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• 

  Jill Marie Drury

  Jill Drury, Pharm.D., MBA, is a medical director for AbbVie. She has decades of diverse healthcare experience and is known for supporting and improving patient access through strategic thinking and authentic communication.
• 

  Podcast

  BioMarin Fails to Reassure Investors, Terns Moves Forward in Obesity, ESMO Excitement

  BioMarin’s new business strategy leaves investors with questions; Lykos CEO steps down; Terns releases compelling data on oral weight loss candidate; and more.

  September 11, 2024

   · 

  1 min read

   · 

  Heather McKenzie
• 

  Diabetes

  Lilly Continues Once-Weekly Insulin Rally With Two Phase III Diabetes Readouts

  The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for patients with type 1 and 2 diabetes, respectively.

  September 11, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Pharmacy benefit managers

  Can PBM Reform Lower Drug Prices?

  Healthcare players are pointing fingers amid regulatory crackdowns on pharmacy benefit managers, but proposed reforms wouldn’t address a dearth of competition in the larger market.

  September 11, 2024

   · 

  5 min read

   · 

  Keerthi Vedantam
• 

  Gene Therapy

  Vertex, CRISPR’s Casgevy Highlights Complex Path to Gene Therapy Profitability

  No patients have received Casgevy, CRISPR Therapeutics and Vertex Pharmeceuticals’ recently approved sickle cell gene therapy. Experts weigh in on the path to profit for the treatment and the therapeutic class in general.

  September 11, 2024

   · 

  7 min read

   · 

  Annalee Armstrong
• 

  IN PARTNERSHIP WITH IQVIA

  Webinar: Embracing Agility: Critical for the role of QARA professional?

  Join our webinar to explore strategies, best practices, and the evolving landscape of QARA in today’s dynamic market.

  September 11, 2024

   · 

  1 min read
• 

  Job Search Strategy

  Career Coach: Why Fall Is Prime Time for Your Biotech Job Hunt

  Plus, learn about what to expect in initial interviews and how to time your post-Ph.D. job search for maximum success.

  September 11, 2024

   · 

  5 min read

   · 

  Carina Clingman
• 

  Policy

  What Expanded CVD Medicare Coverage May Mean for Novo Nordisk’s Wegovy

  A recent study estimated that Wegovy’s label expansion beyond obesity could push Medicare spending to $145 billion annually, but analysts remain dubious of the estimate.

  September 11, 2024

   · 

  6 min read

   · 

  Nick Paul Taylor
• 

  GLP-1

  Novo’s Saxenda Effectively, Safely Lowers BMI in Children: NEJM Study

  A study published Tuesday in The New England Journal of Medicine showed that children between the ages of six and 12 who took liraglutide for just over a year experienced a significant reduction in body mass index compared to placebo.

  September 11, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Funding

  Bain Raises $3B for Fourth Fund to Back Promising Life Sciences Companies

  Tuesday’s round brings Bain Capital Life Sciences’ fundraising total to around $6.7 billion since its founding in 2016. Many of its portfolio companies have resulted in high-value exits recently, including Cerevel Therapeutics, Aiolos Bio and Jnana Therapeutics.

  September 11, 2024

   · 

  2 min read

   · 

  Tristan Manalac